Veeva Vault CRM vs Salesforce Sales Cloud (2026)

TL;DR

• Pick Veeva Vault CRM if you run field sales, MSLs, and marketing against healthcare providers and need HCP management, territory planning, approved content, and events compliance to work on day one rather than be a build project.
• Pick Salesforce Sales Cloud if your commercial motion is closer to ordinary B2B — distributors, hospital systems, payers, devices sold through procurement — and you value the AppExchange ecosystem, published pricing, and a hiring pool over vertical depth you'd only half-use.

The platform split is the whole story

You cannot evaluate these two without understanding the history. Veeva's original CRM was built on the Salesforce platform. Vault CRM is not — it runs on Veeva's own Vault stack, alongside the rest of the Veeva estate. The two companies are no longer platform partners, and Salesforce now goes to market in life sciences on its own.

That divorce is the single most consequential fact for any pharma buyer in 2026, and it cuts both ways.

If you're a Veeva shop, the move to Vault CRM is not a version upgrade — it's a platform migration, and it should be budgeted like one. If you're a Salesforce shop who liked having your CRM and your Veeva applications on the same substrate, that convenience is gone. And if you're greenfield, you now have two vendors each claiming to be the natural home for a regulated commercial team, which is a genuinely more competitive market than pharma has had in a decade. Do not let either sales team tell you the choice is obvious. It isn't anymore.

What "compliance" actually buys you

The word gets thrown around loosely. Here is what it concretely means in a life-sciences CRM, and where the two products diverge.

Veeva Vault CRM ships HCP management, territory and key account planning, and events compliance as native capability. Its Campaign Manager coordinates field, email, and digital channels as one motion rather than three disconnected ones — which matters because in this industry the constraint isn't "can we send an email," it's "can we prove which approved asset went to which prescriber, when, and under whose sign-off." Vault CRM also sits inside the Veeva data ecosystem: OpenData, Link, Compass, and Network MDM feed reference and performance data natively. That last point is underrated. The hardest part of pharma CRM is not the CRM — it's the customer master. Veeva already owns yours, or wants to.

Salesforce gives you custom objects, Flow, validation rules, and Apex, plus the AppExchange. Every one of those compliance behaviors can be built. Some of it can be bought from ISVs. None of it is there when you sign the contract. For an organization with a strong internal platform team and a genuinely idiosyncratic model, that's freedom. For a 60-rep commercial org that just needs closed-loop marketing and sample accountability to work, it's a nine-month project with a consultancy attached.

Cost, and where it hides

Salesforce publishes list prices: $25/user/mo for Starter, $100 Pro, $175 Enterprise, $350 Unlimited. Nobody in pharma is buying Starter — you're at Enterprise or above, and real total cost of ownership routinely lands well above list once implementation, admin headcount, sandboxes, and add-ons are counted. Salesforce has also raised prices consistently and writes escalators into contracts. Budget accordingly.

Veeva doesn't publish anything. It's enterprise pricing, quote only, and implementation typically runs through Veeva-certified partners. That opacity is a real negotiating disadvantage — you cannot benchmark what you cannot see, and Veeva knows exactly how few credible alternatives you have.

The instinct to say "Salesforce is cheaper because we can see the number" is wrong. The correct comparison is Salesforce license plus the cost of building the vertical against Veeva license with the vertical included. For most pharma commercial teams the build is the expensive half, and it never really finishes — regulations change and someone has to maintain your custom approved-content workflow forever. Model three years, not one.

Where each one is genuinely weak

Veeva's weakness is leverage. It is purpose-built for life sciences and useless anywhere else, which means once you're in, your CRM is not a transferable asset and your negotiating position is poor. Implementation is complex and effectively requires certified partners, so you're paying an ecosystem tax on top of an opaque license. And with roughly 125 commercial customers worldwide, this is a concentrated vendor relationship, not a commodity purchase. If Veeva's roadmap diverges from your needs, you have very little recourse.

Salesforce's weakness is that it doesn't know your industry. The platform is spectacular and the ecosystem is unmatched, but nothing in the box understands a sample disbursement limit or an approved-content sign-off chain. Complexity also scales fast: smaller commercial teams end up paying for a platform they use 20% of, and the total cost of ownership problem — implementation, a permanent admin, AppExchange add-ons — is well documented and real.

Bottom line

If your commercial team's core job is HCP engagement at scale — reps detailing prescribers, MSLs running medical conversations, marketing pushing approved content into that same relationship — Veeva Vault CRM is the default for a reason, and Salesforce will cost you more to reach the same place. If your revenue actually flows through distributors, GPOs, hospital procurement, or payers, and HCP detailing is a side quest, buy Salesforce and stop paying for a vertical you don't run. The question to answer before the demos start is not "which is better." It's "is my commercial motion actually regulated field promotion, or does it just live near it?"